Currently out of the existing stock ratings of Matthew Hershenhorn, 1 are a HOLD (100%).

Matthew Hershenhorn

Work Performance Price Targets & Ratings Chart

Analyst Matthew Hershenhorn, currently employed at OPPENHEIMER,

Wall Street Analyst Matthew Hershenhorn

ACAD ACADIA Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Apr-2025

$36

$10.13 (39.16%)

$26

Hold Since 20-Jun-2022

$25

$-0.87 (-3.36%)

$24

Buy Since 23-Jun-2025

$36

$10.13 (39.16%)

$30

Buy Since 30-Jun-2026

$30

$4.13 (15.96%)

$29

Buy Since 21-Oct-2025

$35

$9.13 (35.29%)

$32

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Matthew Hershenhorn?

On 2025

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?